Approval marks Venus Remedies’ first anti-infective marketing authorization in Indonesia and enables the country’s first generic entry for this critical antibiotic combination
Experts caution that realizing AI’s potential requires careful management and risk mitigation
Vanda strongly disputes the FDA’s reasoning
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The approval is supported by data from three pivotal clinical trials
The company views ESG reporting as a strategic tool to build trust with clients, investors, regulators, and stakeholders worldwide
NGD Infection Prevention was formed to scale the delivery of sequence-based transmission detection
Takeda said zasocitinib was generally well tolerated, with a safety profile consistent with earlier studies
Efdoralprin alfa, a recombinant human alpha-1 antitrypsin (AAT)-Fc fusion protein, showed superior efficacy to standard plasma-derived therapy in adults with AATD
If cleared by regulators, CagriSema would become the first treatment to combine a GLP-1 receptor agonist and a long-acting amylin analogue in a single injection
Subscribe To Our Newsletter & Stay Updated
